L
Lyla Hance
Researcher at University of North Carolina at Chapel Hill
Publications - 7
Citations - 113
Lyla Hance is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Retrospective cohort study & Psychological intervention. The author has an hindex of 4, co-authored 7 publications receiving 54 citations.
Papers
More filters
Journal ArticleDOI
Predictors of Admission After the Implementation of an Enhanced Recovery After Surgery Pathway for Minimally Invasive Gynecologic Surgery.
Dayley S. Keil,Lauren D. Schiff,Erin T. Carey,Janelle K. Moulder,Amy M. Goetzinger,Seema M. Patidar,Lyla Hance,Lavinia Kolarczyk,Robert S. Isaak,Paula D. Strassle,Jay W Schoenherr +10 more
TL;DR: Increased ASA physical status, being African American, and increased length of procedure were significantly associated with admission after LH/RAH performed under an ERAS pathway.
Journal ArticleDOI
Implementation of a pediatric enhanced recovery pathway decreases opioid utilization and shortens time to full feeding.
Michael R. Phillips,William T. Adamson,Sean E. McLean,Lyla Hance,M. Concetta Lupa,Sara L. Pittenger,Pooja Dave,Peggy McNaull +7 more
TL;DR: The study demonstrates that opioid utilization and time to feeding can be positively impacted using ERAS pathways without negatively impacting outcomes.
Journal ArticleDOI
The impact of an enhanced recovery perioperative pathway for pediatric pectus deformity repair
TL;DR: Implementation of the ERAS protocol standardized pectus perioperative care, but did not improve postoperative opioid usage, complications, or resource utilization, according to patients undergoing minimally invasive and traditional corrective procedures.
Journal ArticleDOI
Thoracic Enhanced Recovery After Surgery: Single Academic Center Observations After Implementation
Audrey L. Khoury,Lavinia Kolarczyk,Paula D. Strassle,Cynthia Feltner,Lyla Hance,Emily G. Teeter,Benjamin E. Haithcock,Jason M. Long +7 more
TL;DR: In the first year of implementation, median LOS, complications, and 30-day outcomes did not differ significantly between the pre- and post-ERAS groups, and buy-in and adherence to a new protocol are necessary for implementation to be effective.
Journal ArticleDOI
Increased Intraoperative Vasopressor Use as Part of an Enhanced Recovery After Surgery Pathway for Pancreatectomy Does Not Increase Risk of Pancreatic Fistula.
TL;DR: Aim directed fluid therapy (GDFT) is a core component of ERAS pathways that limit excessive volume administration and is associated with increased use of intraoperative vasopressors, which is not associated with an increase in the risk of clinically significant pancreatic fistulas.